无缺血器官技术移植研究进展
Research progress of ischemia-free organ transplantation
李冶夫 1张明熙 2吴少海 3陈宏珲 2黄金波 2鲁昌涛 1姚尧 1赵强 2何晓顺2
作者信息
- 1. 奇点医疗科技(广州)有限公司,广州 511338
- 2. 中山大学附属第一医院,广州 510062
- 3. 广东省医疗器械质量监督检验所,广州 510663
- 折叠
摘要
近年来,加入移植等待名单的患者数量逐年升高,但由于供体缺乏,因此扩展标准供体(ECD)器官的利用率逐年增高.从改善病人预后、改变肝内代谢,同时避免缺血-再灌注损伤(IRI),实现肝脏活性评估并提高移植物利用率3个方面,总结了无缺血器官移植(IFOT)技术进展,展望了无缺血器官移植的发展前景.无缺血器官移植技术在未来可能会改变器官移植的方式,技术创新和可移动机器灌注设备开发使用将助推该技术的进一步发展.
Abstract
Ischemia-reperfusion injury(IRI)is a congenital defect of organ transplantation.Extended criteria donor(ECD)organs are more susceptible to IRI,resulting in a serious contradiction between supply and demand.Although the breakthrough of machine perfusion technology has brought the hope of alleviating IRI,it still cannot eradicate the organ damage caused by IRI.Ischemia-free organ transplantation can completely avoid IRI,improve graft function,improve the prognosis of patients,and expand the source of graft.This article summarizes the latest progress of ischemia-free organ transplantation,and looks forward to the future development of ischemia-free organ transplantation,so as to help researchers and clinicians in related fields understand the latest research status of ischemia-free organ transplantation and provide reference.
关键词
无缺血器官移植/常温机械灌注/缺血-再灌注损伤/早期同种异体移植物功能障碍Key words
ischemia-free organ transplantation(IFOT)/normothermic machine perfusion(NMP)/ischemia reperfusion injury/early allograft dysfunction引用本文复制引用
基金项目
广东省药品监督管理局科技创新项目(S2022ZDZ012)
出版年
2024
NETL
NSTL
万方数据